Adjunct Professor of Molecular Medicine at the University of Helsinki, Finland
Her research focuses on understanding molecular mechanisms behind diseases with genetic and acquired mitochondrial abnormalities. Her ultimate goal is to develop novel mitochondrial activating treatments and she is currently investigating vitamin B3 as a mitochondrial booster.
She received her PhD in Molecular Medicine at the University of Eastern Finland in 2009, worked in Switzerland for four years and in 2015 came back to run her own laboratory at the University of Helsinki, when she received the prestigious Academy Research Fellowship.
The focus of Eija Pirinen research is to investigate molecular mechanisms behind diseases characterized with genetic or acquired mitochondria dysfunction such as inherited mitochondrial disorders, obesity and type 2 diabetes.
See also: University of Helsinki - Multidisciplinary research university.
Eija Pirinen News
Vitamin B3 is a good option to correct the NAD+ deficit in humans
Phys.org - 14-May-2020
NAD+ deficiency is for real and it happens in humans tooRead more...